Chemical Structure : NRL-1049
CAS No.: 1973494-16-4
Catalog No.: PC-20084Not For Human Use, Lab Use Only.
NRL-1049 ((R)-BA-1049) is a potent, orally-available ROCK2-selective inhibitor with IC50 of 0.24 uM, 16-fold selectivity over ROCK-1.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 5 mg | $138 | In stock | |
| 10 mg | $218 | In stock | |
| 25 mg | $378 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
NRL-1049 ((R)-BA-1049) is a potent, orally-available ROCK2-selective inhibitor with IC50 of 0.24 uM, 16-fold selectivity over ROCK-1.
Neither BA-1049 nor the metabolite inhibits PKA or PKC at physiological ATP concentrations.
BA-1049 is a promising drug candidate to reduce lesion growth and hemorrhage in both CCM1 and CCM3 models of cavernous angioma (CA).
| M.Wt | 319.42 | |
| Formula | C16H21N3O2S | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
(R)-1-(1-(isoquinolin-5-ylsulfonyl)piperidin-4-yl)ethan-1-amine |
|
1. Lisa McKerracher, et al. Transl Stroke Res. 2020 Jun;11(3):365-376.
2. Patent US20170313680A1.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright